智通财经APP获悉，和誉-B(02256)早盘涨超5%，截至发稿，涨5.04%，报5.21港元，成交额747.02万港元。
消息面上，和誉此前发布盈喜，预期去年总收入约为5.04亿元人民币，同比增加约4.85亿元；及溢利不低于1,000万元，而2023年亏损约为4.32亿元，实现扭亏为盈。
公告称，除了透过提高业务营运效率来改善成本控制外，预计总收入的增长及扭亏为盈亦主要归因于pimicotinib(ABSK021)的对外许可协议及与默克公司的首付款项7000万美元(人民币4.97亿元)，其对截至2024年12月31日止年度的收入作出重大贡献。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.